Immunai Raises $60M to Reprogram Immunity
Similar Posts
Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-powered Cancer Diagnostics in Pathology
Ibex’s AI technology helps physicians and providers diagnose cancer with greater real-time accuracy by reducing error and misdiagnosis…
Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…
Reveleer Launches Prospective Risk Adjustment Enhancements, Leveraging AI to Close Care Gaps Proactively
Capabilities deliver essential pre-encounter patient information to the point of care for prospective and concurrent review Reveleer, a healthcare…
HHS Announces Funding for Health Information Exchanges to Support Public Health Agencies – STAR HIE Program Funds Five Organizations to Improve Interoperability of Health Data
The U.S. Department of Health and Human Services (HHS) today announced today five cooperative agreements to health information exchange…
